Clinical Trial Update: Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating whether the quadrivalent HPV vaccine reduces relapses of genital warts after initial therapeutic response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Warts

Drugs mentioned

• Gardasil (human papillomavirus vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Genital Warts | Phase 3 | Status: UNKNOWN